zoledronic acid has been researched along with Spinal Cord Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, JW; Chen, SM; Hsieh, LL; Li, YY; Yeh, KY | 1 |
1 other study(ies) available for zoledronic acid and Spinal Cord Neoplasms
Article | Year |
---|---|
Low-dose zoledronic acid reduces spinal cord metastasis in pulmonary adenocarcinoma with neuroendocrine differentiation.
Topics: Animals; Antineoplastic Agents; Carcinoma, Neuroendocrine; Cell Differentiation; Cell Line, Tumor; Cloning, Molecular; Diphosphonates; Dose-Response Relationship, Drug; Flow Cytometry; Gene Knockdown Techniques; Green Fluorescent Proteins; Imidazoles; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplasm Transplantation; Neural Cell Adhesion Molecules; RNA, Small Interfering; Spinal Cord Neoplasms; Transfection; Zoledronic Acid | 2012 |